The Effect of Glycoprotein IIb/IIIa Receptor Inhibitor on the Microcirculation in Patients Undergoing High-Risk Coronary Stenting; A Prospective, Randomized Study

Author： Wong Philip   Harding Scott   Inglessis Ignacio   Choi C. Joon   Walters Darren   Chang Yuchiao   Gimelli Giogio   Jang Ik-Kyung  

Publisher： Springer Publishing Company

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.16, Iss.3, 2003-12, pp. : 163-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycoprotein IIb/IIIa receptor antagonists in acute myocardial infarction and primary coronary stenting: Not always effective

By Banai Shmuel   Medina Aharon   Keren Andre  

International Journal of Cardiovascular Interventions, Vol. 3, Iss. 4, 2000-12 ,pp. : 241-243

Informa Healthcare

Access to resources Recommend Favorite

Argatroban Anticoagulation in Conjunction with Glycoprotein IIb/IIIa Inhibition in Patients Undergoing Percutaneous Coronary Intervention: An Open-Label, Nonrandomized Pilot Study

By Jang Ik-Kyung   Lewis Bruce E.   Matthai William H.   Kleiman Neal S.  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 1, 2004-08 ,pp. : 31-37

Springer Publishing Company

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa inhibitor associated severe thrombocytopenia in patients with coronary artery disease: Clinical course and outcomes

By Viswanathan Girish   Kidambi Ananth   Nelson Adam   Mayurathan Gnanamoorthy   Hardy John   Kesteven Patrick   Zaman Azfar  

Platelets, Vol. 23, Iss. 3, 2012-05 ,pp. : 224-228

Informa Healthcare

Access to resources Recommend Favorite

Safety, inhibition of platelet aggregation and pharmacokinetics of F(ab′)2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty

By Mazurov A.V.   Pevzner D.V.   Antonova O.A.   Byzova T.V.   Khaspekova S.G.   Semenov A.V.   Vlasik T.N.   Samko A.N.   Staroverov I.I.   Ruda M.Ya.  

Platelets, Vol. 13, Iss. 8, 2002-12 ,pp. : 465-477

Informa Healthcare

Access to resources Recommend Favorite

The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary

By  

Current Cardiology Reviews, Vol. 4, Iss. 4, 2008-11 ,pp. : 293-299

Bentham Science Publishers

Access to resources Recommend Favorite